Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors.

CONCLUSIONS: The systemic immune-inflammation index is useful for establishing a more sophisticated prognostic model that can stratify mRCC patients into four groups with different prognoses.
PMID: 32520703 [PubMed - as supplied by publisher]

Source: Canadian Urological Association Journal - June 4, 2020 Category: Urology & Nephrology Authors: Teishima J, Inoue S, Hayashi T, Matsubara A, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Moriyama H, Fujiwara S Tags: Can Urol Assoc J Source Type: research